Calcified Tissue International

, Volume 77, Issue 2, pp 113–118 | Cite as

Association of COLIA1 Sp1 Alleles with Defective Bone Nodule Formation In Vitro and Abnormal Bone Mineralization In Vivo

  • T. L. Stewart
  • P. Roschger
  • B. M. Misof
  • V. Mann
  • P. Fratzl
  • K. Klaushofer
  • R. Aspden
  • S. H. Ralston


Previous work identified a G/T polymorphism affecting a Sp1 binding site in a regulatory region of the COLIA1 gene that predisposes to osteoporotic fractures by affecting bone strength through mechanisms that are partly independent of differences in bone mineral density (BMD). To clarify the mechanisms by which COLIA1 Sp1 alleles influence bone strength we used quantitative backscattered electron imaging (qBEI) to characterize bone mineralization in biopsy samples from subjects of different COLIA1 genotype and studied the ability of osteoblast-like cells cultured from subjects of different genotypes to form mineralized bone nodules. The qBEI analysis showed a significant (P = 0.014) reduction in mineralization in bone biopsies from G/T heterozygotes (n = 6) compared with G/G homozygotes (n = 7) and a significant increase in heterogeneity of mineralization (P = 0.017). The in vitro studies showed that osteoblasts derived from G/T heterozygotes (n = 5) were significantly less able to produce mineralized bone nodules than G/G homozygotes (n = 10) at all time-points examined (P < 0.0001). We conclude that carriage of the COLIA1 Sp1 “T” allele is associated with an impaired ability of osteoblast-like cells to form mineralized bone nodules in vitro and with abnormalities of bone mineralization in vivo. This suggests that the increased bone fragility in carriers of the COLIA1 Sp1 allele may result in part from defects in bone mineralization.


Collagen Polymorphism Genetic Osteoporosis Mineralization 


  1. 1.
    Kanis, JA, Melton, LJ,III, Christiansen, C, Johnston, CC, Khaltaev, N 1994The diagnosis of osteoporosisJ Bone Miner Res911371141PubMedGoogle Scholar
  2. 2.
    Efstathiadou, Z, Tsatsoulis, A, Ioannidis, JP 2001Association of collagen I alpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysisJ Bone Miner Res1615861592PubMedGoogle Scholar
  3. 3.
    Mann, V, Ralston, SH 2003Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fractureBone32711717CrossRefPubMedGoogle Scholar
  4. 4.
    Bornstein, P, McKay, J 1988The first intron of the alpha 1(I) collagen gene contains several transcriptional regulatory elementsJ Biol Chem26316031606PubMedGoogle Scholar
  5. 5.
    Mann, V, Hobson, EE, Li, B, Stewart, TL, Grant, SF, Robins, SP, Aspden, RM, Ralston, SH 2001A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and qualityJ.Clin Invest107899907PubMedGoogle Scholar
  6. 6.
    McGuigan, FE, Reid, DM, Ralston, SH 2000Susceptibility to osteoporotic fracture is determined by allelic variation at the Sp1 site, rather than other polymorphic sites at the COL1A1 locusOsteoporos Int11338343CrossRefPubMedGoogle Scholar
  7. 7.
    Roschger, P, Fratzl, P, Eschberger, J, Klaushofer, K 1998Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies [see comments]Bone23319326CrossRefPubMedGoogle Scholar
  8. 8.
    Roschger, P, Plenk, H,Jr., Klaushofer, K, Eschberger, J 1995A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensitiesScanning Microsc97586PubMedGoogle Scholar
  9. 9.
    Roschger, P, Gupta, HS, Berzlanovich, A, Ittner, G, Dempster, DW, Fratzl, P, Cosman, F, Parisien, M, Lindsay, R, Nieves, JW, Klaushofer, K 2003Constant mineralization density distribution in cancellous human boneBone32316323CrossRefPubMedGoogle Scholar
  10. 10.
    Beresford, JN, Gallacher, JA, Gowen, M, McGuire, MKB, Poser, J, Russell, RGG 1983Human bone cells in culture. A novel system for the investigation of bone cell metabolismClin Sci643839Google Scholar
  11. 11.
    Johnson, K, Hashimoto, S, Lotz, M, Pritzker, K, Goding, J, Terkeltaub, R 2001Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcificationArthritis Rheum4410711081CrossRefPubMedGoogle Scholar
  12. 12.
    Roschger, P, Rinnerthaler, S, Yates, J, Rodan, GA, Fratzl, P, Klaushofer, K 2001Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic womenBone29185191CrossRefPubMedGoogle Scholar
  13. 13.
    Garnero,  2000Markers of bone turnover for the prediction of fracture riskOsteoporos Int 11 Suppl6S55S65CrossRefGoogle Scholar
  14. 14.
    Keen, RW, Woodford-Richens, KL, Grant, SF, Ralston, SH, Lanchbury, JS, Spector, TD 1999Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnoverArthritis Rheum42285290CrossRefPubMedGoogle Scholar
  15. 15.
    Langdahl, BL, Ralston, SH, Grant, SFA, Eriksen, EF 1998An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in men and womenJ Bone Miner Res1313841389PubMedGoogle Scholar
  16. 16.
    Qureshi, AM, Herd, RJ, Blake, GM, Fogelman, I, Ralston, SH 2002COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapyCalcif Tissue Int70158163CrossRefPubMedGoogle Scholar
  17. 17.
    Boivin, GY, Chavassieux, PM, Santora, AC, Yates, J, Meunier, PJ 2000Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic womenBone27687694CrossRefPubMedGoogle Scholar
  18. 18.
    Follet, H, Boivin, G, Rumelhart, C, Meunier, PJ 2004The degree of mineralization is a determinant of bone strength: a study on human calcaneiBone34783789CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • T. L. Stewart
    • 1
  • P. Roschger
    • 2
  • B. M. Misof
    • 2
  • V. Mann
    • 4
  • P. Fratzl
    • 3
  • K. Klaushofer
    • 2
  • R. Aspden
    • 1
  • S. H. Ralston
    • 4
  1. 1.Department of Medicine and Therapeutics University of Aberdeen Medical SchoolUK
  2. 2.Ludwig Boltzmann Institute of Osteology4th Med. Dept., Hanusch Hospital & UKH MeidlingViennaAustria
  3. 3.Max-Planck-Institute of Colloids and InterfacesDepartment of BiomaterialsGermany
  4. 4.Rheumatic Diseases Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Western General HospitalEdinburgh EH42XUUK

Personalised recommendations